Summary
Definition
History and exam
Key diagnostic factors
- uterine bleeding
Other diagnostic factors
- use of medications
- menstrual irregularity
- anaemia
- premenstrual molimina
- hirsutism, acne, acanthosis nigricans
- existing medical illness
Risk factors
- women at the extremes of reproductive age (just after puberty and before menopause)
- polycystic ovary syndrome
- endocrine disorders
- other anovulatory disorders
- obesity
Diagnostic investigations
1st investigations to order
- pregnancy test
- FBC
Investigations to consider
- coagulation profile
- serum TSH level
- ultrasound scan
- hysteroscopy
- endometrial biopsy
Treatment algorithm
emergency management of excessive uterine bleeding
anovulatory AUB: progestogens and oestrogens not contraindicated
anovulatory AUB: progestogens and oestrogens contraindicated
significant uterine bleeding resistant to medical treatment; desiring future fertility
significant uterine bleeding resistant to medical treatment; not desiring future fertility
Contributors
Authors
Janesh Gupta, MSc, MD, FRCOG
Professor of Obstetrics and Gynaecology
Centre for Women's and Newborn Health
Institute of Metabolism and Systems Research
University of Birmingham
Birmingham Women’s and Children’s Hospital
Birmingham
UK
Disclosures
JG is a clinical advisor for Femcare UK.
Akanksha Sood, MBBS, MS (OBGY), DNB, MRCOG, FACOG
Senior Clinical Fellow
Department of Reproductive Medicine
St. Mary’s Hospital
Manchester
UK
Disclosures
AS declares that she has no competing interests.
Rohan Chodankar, MBBS, MD, MRCOG
ST6 Obstetrics and Gynaecology
Royal Infirmary of Edinburgh
Scotland
UK
Disclosures
RC is supported as a Clinical Research Fellow by Bayer AG; RC is an author of references cited in this topic.
Acknowledgements
Professor Gupta, Dr Sood, and Dr Chodankar would like to gratefully acknowledge Dr Mohamed Mitwally and Dr Intisar Elnahhas, the previous contributors to this topic.
Disclosures
MM owns a patent on the use of aromatase inhibitors for endometrial thinning before hysteroscopic surgery. The patent is licensed to Meditrina Company. IE declares that she has no competing interests.
Peer reviewers
Janet Albers, MD
Associate Professor
Department of Family and Community Medicine
Southern Illinois University School of Medicine
Springfield
IL
Disclosures
JA is an author of a reference cited in this topic.
Sarina Schrager, MD, MS
Associate Professor (CHS)
Department of Family Medicine
University of Wisconsin
WI
Disclosures
SS declares that she has no competing interests.
Differentials
- Pregnancy-related bleeding
- Menstrual-related migraine
- Genital lesions
More DifferentialsGuidelines
- General approaches to medical management of menstrual suppression
- Heavy menstrual bleeding: assessment and management
More GuidelinesPatient information
Heavy periods
More Patient information- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer